key: cord-0837976-tff5skxi
authors: Elmehraoui, O.; Berrabeh, S.; Messaoudi, N.; Derkaoui, N.; Zerrouki, D.; Rouf, S.; Latrech, H.
title: Monitoring of type 2 diabetic patients during the ‘Covid 19’ pandemic by teleconsultation
date: 2022-04-29
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2022.103689
sha: 4095036c052fc31083c8153bbb650669ab83c263
doc_id: 837976
cord_uid: tff5skxi

Introduction: Glycemic control in type 2 diabetic patients is a constant challenge. The objective of our study is to evaluate glycemic control in type 2 diabetic patients since the start of the "Covid-19" pandemic by comparing their glycemic and degenerative profiles in the pre-confinement,per and post-confinement periods. Patients and methods: This is a descriptive and analytical,cross-sectional study,bringing together 720 type 2 diabetic patients followed by teleconsultation at the endocrinology,diabetology and nutrition department,from mid-March to mid-October 2020. Results: The mean age of the patients was 62.5 ± 11.3 years, with a sex ratio (M / F) of 0.71,the average duration of diabetes was 10.6 ± 7, 4 years.The mean pre-lockdown Hba1c level was 8.5±1.9%.Only 137 patients have been able to do the HBa1c test since the start of lockdown,which averaged 8.4 ± 1.8%.Regarding the degenerative complications installed after containment,4.4% of the patients presented an acute coronary syndrome,2.2% a cerebrovascular accident,1.4% developed a stage 2 chronic renal disease,and a foot injury appeared in 5.1% of patients while no patient developed diabetic retinopathy among those who performed ophthalmic evaluation.In our series,the death rate was estimated at 1.8%.Drug therapy was adjusted in the majority of patients with initiation of insulin therapy in 7.2% of patients and intensification of insulin doses in 9.4% of patients. Conclusion: At the heart of the pandemic Covid-19 crisis,teleconsultation has taken an essential place in the strategy of access to care, particularly the monitoring of chronic diseases,the results of our study are similar to those of other studies published during this pandemic.

Since the discovery in December 2019, in Wuhan, China, of a group of people with pneumonia of unknown cause and the identification of the new coronavirus "SARS-CoV2" as responsible for this pneumonia currently called 'Covid-19', the whole world is facing this new progressive, serious and highly contagious with community transmission infection [1, 2] . It was declared a pandemic by the World Health Organization (WHO) on March 11, 2020 [3] . As of October 15 th 2020, 38,966,868 cases have been reported worldwide and 1,098,937 people have died of it [4] , with 163,650 confirmed cases in Morocco including 6,087 in the eastern region [5] .

Some studies showed that SARS-CoV-2 or Covid-19 infection seems more severe in the elderly and with co-morbidities, in particular diabetes mellitus, hypertension, cardiovascular pathologies, obesity, kidney disease, and chronic respiratory disease [6] . Thus, diabetes mellitus is considered to be a risk factor for the progression and poor prognosis of Covid-19 [1, 7] .

In the light of these findings, and given the state of health emergency in Morocco, a strategy for reorganizing hospitals has been developed, limiting scheduled hospitalizations and reserving most of the bed service capacity for emergency management and of cases with Covid-19. To best adapt to this situation, we have decided to adopt a teleconsultation program to ensure continuity of care for the benefit of our diabetic patients. Despite the difficulties of managing the teleconsultation and the burden of the task, the medical team provided it with courage and dedication.

The objective of our study is to assess glycaemic control in type 2 diabetic patients during the Covid-19 pandemic by comparing their glycaemic and degenerative profiles in the preconfinement, per and post-confinement period. The secondary objective is to appreciate the utility and the limitations of teleconsultation as an alternative means of follow-up in type 2 diabetic patients.

This is a descriptive and analytical study, with cross-sectional data collection, on insufficiently controlled and complicated type 2 diabetic patients monitored via teleconsultation provided by our team of department of endocrinology, diabetology and nutrition. Teleconsultation debuted at the time of declaration of the state of health emergency by the Moroccan authorities, since mid-March 2020 and at present given the limitation in the number of daily face-to-face consultations imposed by our hospital structure ( Figure 1 ).

We contacted 720 type 2 diabetic patients during the study period, of which 61.8% were reachable, while the remainder or 38.2% were unreachable on the telephone numbers noted in their medical records. Among the people who could be reached, only 137 patients were able to do their check-ups: 2.9% during the first phase of deconfinement, 10.9% during the second phase and 86.1% during the third phase, while the majority of patients refused to do their checkups for fear of going to medical laboratories ( Figure 2 ).

Data collection was compiled from the clinical patient diary available on the 'Hosix' platform in the form of computerized medical records. The patient's contact details including first and last name, patient index, telephone number were collected from the "patient history" section. The technical means used were mainly the smartphones with regular phone calls that last around 15 to 30 minutes as their main mode of communication, which can be followed up by messages and audios.

During the teleconsultation, the doctor must conduct a careful interview with the diabetic patient by looking for glycaemic fluctuations (the number of minor and major hypoglycaemia) by analysing the self-monitoring of blood glucose sent by the patient via the network social 'WhatsApp', thus, screening for signs pointing to complications such as angina, claudication, subjective sensory disorder and in case of foot lesions. Video or photography could be used for inspection of the wound even if teleconsultation can in no way replace the clinical examination. The detection of dietary and therapeutic errors is essential in this telephone interview and when it is deemed insufficient, the patient is called for a face-to-face consultation by issuing the necessary certificate to be authorized to travel to the hospital during the period of confinement.

After the declaration of the first phase of lockdown, a metabolic and degenerative assessment was requested for these patients including the Hba1c level, the lipid profile, the renal function and the dosage of microalbuminuria as well as the ophthalmic examination. Any biological or radiological assessment carried out is sent by the patient, analysed and saved by the doctor in the medical file in order to maintain the confidentiality of patient data.

After having received all the necessary elements, a possible therapeutic adjustment is recommended, namely, a change of the molecules or their dosages, the initiation or the intensification of the insulin regimens, delivered via the same social network in the form of prescriptions. which must bear the name and first name of the patient, the date of the prescription, the name of the drug and its dosage, the duration of treatment and the signature of the prescriber.

While knowing that the education of the diabetic patient is the cornerstone of the care, part of the teleconsultation was devoted to dietetic and therapeutic advice which are individualized for each patient, relating to a healthy and balanced diet, a regular physical activity at home (dancing, aerobics, cycling, treadmill, etc.), muscle strengthening and stretching exercises, not to mention a reminder of preventive measures against Covid-19 and with emphasis on influenza and pneumococcal vaccination.

Statistical analysis was performed by SPSS version 21 software. Descriptive statistics were mentioned for all variables: means, percentages and standard deviation. The McNemar test was used to compare the mean values. For all statistical tests, a p-value less than 0.05 was considered statistically significant. Our study has been reported following the STROCSS 2021 criteria [8] . The mean age of the patients was 62.5 ± 11.3 years, with a sex ratio (M / F) of 0.71, the average duration of diabetes was 10.6 ± 7.4 years. Arterial hypertension was noted in 20% of patients, dyslipidaemia and metabolic syndrome were observed in 19% and 21.2% of cases, respectively.

Before the lockdown period, 6.9% of the patients studied had already had at least one decompensation of their diabetes, 17% presented minor episodes of hypoglycaemia, to due to one hypoglycaemia per week in 5.5% of patients. Degenerative complications were found in 80% of patients, 34.4% were followed for macrovascular and 46.6% had at least one of the microvascular complications ( Table 1 ).

The average level of Hba1c before containment was 8. During the teleconsultation, it was found that 13.1% of the patients installed the complications of diabetes, 4.4% presented an acute coronary syndrome, 2.2% a cerebrovascular accident and concerning a Lower extremity arterial occlusive disease, none of the patients reported intermittent claudication. Only 1.4% of patients developed stage 2 chronic renal disease, and Feet lesion occurred in 5.1% of patients, while no patient developed diabetic retinopathy among those who developed an ophthalmic examination. In our series, the death rate was estimated at 1.8%. Drug therapy was adjusted in the majority of patients. Insulin therapy was initiated in 7.2% of patients and insulin doses were intensified in 9.4% of patients (Table 2 ). J o u r n a l P r e -p r o o f During this pandemic, the National Council of the Order of Doctors allowed the use of teleconsultation to ensure remote monitoring of patients, especially those with chronic diseases or cancer, the elderly and pregnant women.

Teleconsultation puts patients in contact with their treating doctors in the comfort of their homes. Interviews and electronic prescription delivery have enabled thousands of patients to continue their care without exposing themselves or increasing the risk of contamination.

Reporting the experience of the source of the pandemic, in January 2020 China activated a multimodal telemedicine network in Sichuan province, it synergizes a newly established 5G service, a smartphone application and a telemedicine system that is proven to be feasible, acceptable and effective in enabling significant improvement in health care outcomes [19] . The same, video consultations have been encouraged and extended to reduce the risk of transmission, particularly in the United Kingdom [20] , in the United States [21] , thus, other telemental health services have been inaugurated in China. [22] and in Australia [23] .

Indeed, analysis of the results of our study showed that the mean Hba1c level did not increase as expected during the teleconsultation period. Our results are similar to those of other studies reporting the experience of teleconsultation as a means of monitoring diabetic patients. In fact, in a study conducted in China involving a population of type 2 diabetic patients (n: 3514) who benefited from teleconsultation, a reduction in HbA1c of 0.37% (p <0.001) was noted [24] . Same result obtained by Flodgren et al. by objectifying a reduction in HbA1c of 0.31% (p <0.001) in the patients [25] . In a recently published meta-analysis of 46 studies including patients with type 2 diabetes (n: 24,000). There was an overall mean reduction in HbA1c of (0.01% to 1.13%) [26] .

Likewise, the occurrence of complications, especially degenerative ones, was not so affected. The degenerative complications that occurred in our patients could be due to the natural progression of the diabetic disease, but the conditions of confinement also represent potential risk factors that would be associated with poor glycaemic control like sedentarity lifestyle. In fact, a large part of the population has been forced to work from home, with two consequences; a loss of muscle mass and weight gain which led to a decrease in insulin sensitivity. The challenge also lies in the increased calorie intake compared to daily energy expenditure. The boredom and the stress generated by confinement can also be a factor of glycaemic imbalance.

The results of our study are limited by several factors that must be taken into consideration; the number of patients who underwent a metabolic and degenerative assessment was limited; the short duration of the study in a very particular context of major health crisis. On the other hand, we were faced with considerable difficulties during this study, in particular the interviews and dietary and therapeutic education with illiterate patients, without forgetting the technical problems which are known for telemedicine, namely the problems of connection, video resolution and sound.

While knowing that the normal consultation of a patient with type 2 diabetes is very heavy, we must not forget that teleconsultation is even more so. These results are achieved thanks to the valuable work and commitment of the medical team of the diabetology and nutrition endocrinology service, despite the unfavourable conditions experienced during the period of confinement by the patients and which all promote glycaemic imbalance, including the sedentary lifestyle, change in eating behaviour [27] , decrease in the purchasing power of families which in particular limits the performance of daily self-monitoring of blood glucose.

J o u r n a l P r e -p r o o f

At the heart of the Covid-19 pandemic crisis, teleconsultation has taken on an essential place in the access to care strategy since it is a validated and recommended tool for monitoring diabetic patients. Our experience noted general satisfaction and the teleconsultation was well received by our patients. However, data remains limited and further studies are needed to confirm the long-term impact of teleconsultation.

The authors declare no conflicts of interest.

This research was not funded.

A written informed consent was obtained from the patients for publication of this cohort study and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Not commissioned, externally peer reviewed.

[9] P. Schuetz, P. 

Diabetes and COVID-19

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

COVID-19): situation report, 51, World Health Organization

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches

Diabetes is a risk factor for the progression and prognosis of COVID-19

STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery

Telemedicine During the COVID-19 Pandemic: Experiences From Western China

Video consultations for covid-19

Virtually Perfect? Telemedicine for Covid-19

Online mental health services in China during the COVID-19 outbreak

The Role of Telehealth in Reducing the Mental Health Burden from COVID-19 | Telemedicine and e-Health

Clinical-and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Interactive telemedicine: effects on professional practice and health care outcomes

Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses

COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus

Name of the registry

Unique Identifying number or registration ID

Hyperlink to your specific registration

J o u r n a l P r e -p r o o f Highlights: § Glycemic control in type 2 diabetic patients is a constant challenge, particularly in a pandemic situation. § At the heart of the Covid-19 pandemic crisis, teleconsultation has taken on an essential place in the access to care strategy. § In our study, the mean Hba1c level did not increase during the teleconsultation period.J o u r n a l P r e -p r o o f

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.The authors declare no conflicts of interest.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.This research was not funded.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement. This is a cohort study that does not require a formal ethical committee approval. Data were anonymously registered in our database. Access to data was approved by the head of the department.J o u r n a l P r e -p r o o f Consent Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.A written informed consent was obtained from the patients for publication of this cohort study and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors.Dr. Elmehraoui Ouafae wrote the manuscript .Dr. Berrabeh Soumiya helped in writing and exploitation of patient data.Dr. Elmessaoudi Najoua helped in writing and exploitation of patient data. Dr. Derkaoui Nada helped in exploitation of patient data. Dr. Dounia Zerrouki helped in exploitation of patient data. Pr. Siham Rouf helped in writing, supervised the redaction and revised the manuscript. Pr. Hanane Latrech helped in writing, supervised the redaction, revised and approved the final draft for publication. All authors approved the final version of the manuscript.J o u r n a l P r e -p r o o f

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.